ArticleJTO clinical and research reports2021

Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated Metastatic

Kazuto Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.